Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease.
about
Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD--the ABACOPD study.F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based StudyClinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry.The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trialDeterminants for changing the treatment of COPD: a regression analysis from a clinical audit.Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.Oral inflammation and infection, and chronic medical diseases: implications for the elderly.Predicting In-Hospital Treatment Failure (≤ 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids.Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations.Effectiveness of treatment with nebulized colistin in patients with COPDDoes a single Pseudomonas aeruginosa isolation predict COPD mortality?Interventions to improve adherence to first-line antibiotics in respiratory tract infections. The impact depends on the intensity of the intervention.Recommendations for the pharmacological treatment of COPD: questions and answers.Upper airway microbial colonization in patients with neuromuscular disorders.Antibiotic-induced population fluctuations and stochastic clearance of bacteria.The Role of the Immune Response in the Pathogenesis of Bronchiectasis.
P2860
Q35149431-149103AB-B522-4954-AA8C-7F42BEBC87F5Q35630919-E3F0D84B-28A8-404D-ACD9-85DA6A64B75FQ35754952-2F7AA53C-D528-44EA-A3E6-6492CAD1B288Q36380278-F51F0D51-3B1C-4FF9-A9AE-B96F4E8B48DDQ36763617-3FE2A554-390C-4C2E-B795-95EF1D00CE3AQ36981197-8507AAB7-A803-45BA-9414-5B82FD85C653Q38679715-E22051A6-09A8-4DCA-8BC9-DA5106DBDA9EQ38921866-B7FD73B8-F45A-4A78-8643-61D9C7C1C9AFQ40448715-2F482985-1EA8-4A6A-8DB0-E43D7C85564FQ41992671-D7F58ED3-E723-48E7-BA89-6EED5D1430BAQ42373825-12A0095D-2014-4DA5-925D-F88AB164ECBEQ42852572-4A45E8B5-78D3-4169-AA61-D4E0C2F20098Q46106776-2D09160D-A79E-464C-9900-C1B60B7A6D60Q47272746-F370DBC9-6344-4DC5-9357-792F58813318Q47853699-E6B2A7FA-2824-4A25-A662-830D36790A7CQ52672344-C8FDEC73-056E-4A0E-A131-0E8C702F6C85Q55029817-121E84A2-1A63-4ACF-8217-0596D15D41D8
P2860
Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antibiotics for treatment and ...... obstructive pulmonary disease.
@en
type
label
Antibiotics for treatment and ...... obstructive pulmonary disease.
@en
prefLabel
Antibiotics for treatment and ...... obstructive pulmonary disease.
@en
P1433
P1476
Antibiotics for treatment and ...... obstructive pulmonary disease.
@en
P2093
Robert Wilson
Sanjay Sethi
P304
P356
10.1016/J.JINF.2013.08.010
P577
2013-08-22T00:00:00Z